Why is Shingrix (recombinant zoster vaccine) not included in the list of vaccines that can be kept at room temperature for more than four hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Shingrix Storage Requirements: Why It Cannot Be Kept at Room Temperature

Shingrix is not included in the list of vaccines that can be kept at room temperature for more than four hours because it is a lyophilized (freeze-dried) vaccine with an adjuvant suspension component that requires strict refrigeration at 2°C-8°C (35°F-46°F) to maintain potency and stability. 1

Vaccine Composition and Storage Sensitivity

Shingrix has a unique two-component formulation that makes it particularly temperature-sensitive:

  • Lyophilized antigen component: A white powder containing the recombinant varicella zoster virus glycoprotein E (gE) antigen
  • AS01B adjuvant suspension: An opalescent liquid containing MPL (3-O-desacyl-4'-monophosphoryl lipid A) and QS-21 saponin in a liposomal formulation with DOPC and cholesterol 1

The adjuvant system in Shingrix is particularly vulnerable to temperature excursions. The liposomal formulation and the aluminum-free adjuvant components require continuous refrigeration to maintain their structural integrity and immunogenic properties.

Why Temperature Control Is Critical

Vaccines containing adjuvants are especially susceptible to potency loss from improper storage temperatures. While Shingrix doesn't contain aluminum adjuvant (which precipitates when frozen), its AS01B adjuvant system with liposomal components is sensitive to both heat and temperature fluctuations 2.

The general principles of vaccine cold chain management emphasize that:

  • Temperature effects on vaccine potency from warmth are usually gradual and predictable
  • However, vaccines with complex formulations (like adjuvanted vaccines) can experience more rapid degradation
  • Physical changes may not be visible even when potency is compromised 2

Storage Requirements in Practice

Shingrix must be stored refrigerated at 2°C-8°C continuously until reconstitution and immediate use. 1 Once reconstituted, the vaccine should be administered promptly and cannot be stored for extended periods at room temperature.

Key Storage Pitfalls to Avoid:

  • Never store near freezer outlets: Combination refrigerator/freezer units can create temperature zones that may inadvertently freeze or overheat vaccines 2
  • Avoid door storage: Temperature fluctuations are greatest in refrigerator doors
  • Monitor temperatures twice daily: Document readings when opening and closing the clinic 2
  • Use dedicated vaccine refrigerators: Do not store food or beverages with vaccines 2

Clinical Implications

The strict storage requirements don't diminish Shingrix's clinical value. The vaccine demonstrates:

  • 91.3% efficacy in preventing herpes zoster in adults ≥70 years 1
  • 88.8% efficacy in preventing postherpetic neuralgia 1
  • Sustained protection over 11+ years of follow-up 1
  • Superior effectiveness compared to live zoster vaccine 3

The stringent cold chain requirements exist precisely because maintaining the adjuvant's integrity is essential for achieving these exceptional efficacy rates. 4, 5

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.